Source link : https://www.newshealth.biz/health-news/personalized-neuromodulation-slows-ad-progression/
New research supports the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) for Alzheimer’s disease (AD). In a 52-week phase 2 trial, personalized rTMS applied over the precuneus, a core component of the default mode network (DMN), slowed the progression of cognitive and functional decline in patients with mild to moderate AD. As reported previously […]
Author : News Health
Publish date : 2024-11-12 09:28:49
Copyright for syndicated content belongs to the linked Source.